Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We show that when gene-activated matrices (GAM) are placed between the proximal and distal stumps of severed rat optic nerves, DNA is retained within the GAM, promoting sustained transgene expression in the optic nerve, in the GAM itself, and, more importantly, in axotomized retinal ganglion cells (RGC). Plasmids that encode basic fibroblast growth factor (FGF2), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT3) promote sustained survival of RGC for over 3 months after the initial injury. These findings suggest that immobilized DNA implanted into a CNS lesion will be delivered by axon terminal uptake and retrograde transport to axotomized neurons. GAM may therefore be a useful agent for promoting sustained neuron survival and axon regeneration. Whether further optimization of the matrices, plasmids, promoters, and genes present in the GAM will promote even more survival or, alternatively, axon regeneration remains to be determined.

Original publication

DOI

10.1006/mcne.2001.0975

Type

Journal article

Journal

Mol Cell Neurosci

Publication Date

04/2001

Volume

17

Pages

706 - 716

Keywords

Animals, Axotomy, Brain-Derived Neurotrophic Factor, Cell Line, Cell Survival, Cricetinae, Female, Fibroblast Growth Factor 2, Gene Expression Regulation, Genetic Therapy, Kidney, Neurotrophin 3, Optic Nerve, Optic Nerve Injuries, Plasmids, Rats, Rats, Wistar, Retinal Ganglion Cells, Transfection